Please login to the form below

Not currently logged in
Email:
Password:

Ludwig Hantson

This page shows the latest Ludwig Hantson news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy

Ludwig Hantson, Alexion’s chief executive, said: “The acquisition of Wilson Therapeutics is a strong strategic fit for Alexion given the overlap with our current clinical and commercial focus on metabolic

Latest news

  • Baxalta agrees to $32bn Shire takeover Baxalta agrees to $32bn Shire takeover

    Nevertheless, Baxalta chief executive Ludwig Hantson - who had dismissed Shire's initial overture saying there was little overlap between the companies and that rare disease therapies "require focus" - has now warmed

  • Baxalta spells out opposition to Shire Baxalta spells out opposition to Shire

    Baxalta chief executive Ludwig Hantson said yesterday that Shire's $30bn takeover bid was a "puzzling" approach that would short-change shareholders. ... Hantson insisted Shire's $45-per-share offer is a "lowball valuation" and comes at a time when

  • Shire makes shock $30bn bid for Baxalta Shire makes shock $30bn bid for Baxalta

    Yesterday Shire's CEO Flemming Ornskov wrote to the recently appointed chief at Baxalta, Ludwig Hantson, saying: “ Your lack of engagement has been surprising. ... The specialist in haematology, immunology and cancer therapies has "a solid foundation

  • Baxalta will add $2.5bn in new product turnover by 2020 Baxalta will add $2.5bn in new product turnover by 2020

    The specialist in haematology, immunology and cancer therapies has "a solid foundation and strong momentum," according to Baxter's chief executive-elect Ludwig Hantson, who is due to take charge when

  • Baxter to launch HyQvia in US next week Baxter to launch HyQvia in US next week

    Ludwig Hantson, president of Baxter BioScience.

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics